744 - Impact of COVID-19 Pandemic on Maternal Treatment Programs for Substance Use During Pregnancy

Jenna K. Moses, Creighton University School of Medicine, Phoenix, AZ, United States; Olivia Venvertloh, Creighton University School of Medicine, Phoenix, AZ, United States; Sara C. Esteves, Creighton University School of Medicine, Scottsdale, AZ, United States; Megan A. Witsoe, Creighton University School of Medicine, Scottsdale, AZ, United States; Vanuyen Pham, Creighton University School of Medicine, Phoenix, AZ, United States; Laura M. Cogua, Creighton University School of Medicine, Phoenix, AZ, United States; Pooja Doehrman, Creighton University School of Medicine, Phoenix, AZ, United States; Paul Kang, Creighton University School of Medicine Phoenix, Phoenix, AZ, United States; Hemananda Muniraman, Keck School of Medicine of the University of Southern California, Los Angeles, CA, United States